Medroxyprogesterone Acetate (MPA) CAS 71-58-9: Your Essential Pharmaceutical Intermediate
Unlock the potential of high-quality MPA for advanced pharmaceutical applications.
Get a Quote & SampleProduct Core Value
Medroxyprogesterone Acetate
Medroxyprogesterone Acetate (MPA) is a crucial synthetic progestogen and steroidal progestin, pivotal in the pharmaceutical industry. Derived from progesterone, it serves as a vital API in hormonal therapies and contraception.
- Discover the versatile applications of Medroxyprogesterone Acetate as a key pharmaceutical intermediate.
- Understand the mechanism and benefits of this synthetic progestogen in various medical treatments.
- Explore the different dosage forms and pharmacokinetic profiles of MPA to inform your research and development.
- Gain insights into the safety considerations and potential side effects associated with Medroxyprogesterone Acetate.
Key Advantages of MPA
High Purity and Quality
Ensure your pharmaceutical products meet stringent standards with our high-purity CAS 71-58-9, a trusted synthetic progestogen.
Versatile Pharmaceutical Intermediate
Leverage the broad utility of Medroxyprogesterone Acetate as a building block for advanced pharmaceutical formulations.
Comprehensive Pharmacological Profile
Benefit from MPA's well-documented efficacy in hormonal therapy and contraception, making it a reliable API.
Key Applications
Hormonal Therapy
MPA is instrumental in hormone replacement therapy, addressing conditions like amenorrhea and abnormal uterine bleeding, contributing to women's health.
Contraceptive Development
As a potent progestin, Medroxyprogesterone Acetate is a cornerstone in the development of effective and long-acting contraceptive solutions.
Immunosuppressive Research
Explore the documented immunosuppressive effects of MPA, offering potential applications in immunomodulatory research and treatments.
Pharmaceutical Raw Material
Source reliable Medroxyprogesterone Acetate for your pharmaceutical manufacturing needs, ensuring quality and consistency.